Role of Optical Coherence Tomography in the Prognosis of Vogt–Koyanagi–Harada Disease

References

• Norose K, Yano A. Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 1996;80(11):1002–1008. doi:10.1136/bjo.80.11.1002.
   PubMed Web of Science ®Google Scholar
• Sugita S, Sagawa K, Mochizuki M, Shichijo S, Itoh K. Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease. Int Immunol. 1996;8(5):799–803. doi:10.1093/intimm/8.5.799.
   PubMed Web of Science ®Google Scholar
• Zhou M, Gu RP, Sun Z, Jiang CH, Chang Q, Xu GZ. Differences in photoreceptor recovery among patients and between different parts of the posterior pole in Vogt-Koyanagi-Harada disease. Eye (Lond). 2018;32(3):572–578. doi:10.1038/eye.2017.250.
   PubMed Web of Science ®Google Scholar
• Giordano VE, Schlaen A, Guzman-Sanchez MJ, Couto C. Spectrum and visual outcomes of Vogt-Koyanagi-Harada disease in Argentina. Int J Ophthalmol. 2017;10(1):98–102. doi:10.18240/ijo.2017.01.16.
   PubMed Web of Science ®Google Scholar
• Urzua CA, Velasquez V, Sabat P, et al. Earlier immunomodulatory treatment is associated with better visual outcomes in a subset of patients with Vogt-Koyanagi-Harada disease. Acta Ophthalmol. 2015;93(6):e475–e480. doi:10.1111/aos.12648.
   PubMed Web of Science ®Google Scholar
• Nakayama M, Keino H, Watanabe T, Okada AA. Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids. Br J Ophthalmol. 2019;103(2):274–278. doi:10.1136/bjophthalmol-2017-311691.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Ozyazgan Y, Akova YA, et al. The spectrum of Vogt-Koyanagi-Harada disease in Turkey: VKH in Turkey. Int Ophthalmol. 2007;27(2–3):117–123. doi:10.1007/s10792-006-9001-1.
   PubMedGoogle Scholar
• Herbort CP, Jr. Abu El Asrar AM, Yamamoto JH, Pavesio CE, Gupta V, Khairallah M, et al. Reappraisal of the management of Vogt-Koyanagi-Harada disease: sunset glow fundus is no more a fatality. Int Ophthalmol. 2017;37(6):1383–1395. doi:10.1007/s10792-016-0395-0.
   PubMed Web of Science ®Google Scholar
• Shen E, Rathinam SR, Babu M, et al. Outcomes of Vogt-Koyanagi-Harada Disease: a subanalysis from a randomized clinical trial of antimetabolite therapies. Am J Ophthalmol. 2016;168:279–286. doi:10.1016/j.ajo.2016.06.004.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Hemachandran S, Al-Mezaine HS, Kangave D, Al-Muammar AM. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease. Acta Ophthalmol. 2012;90(8):e603–e608. doi:10.1111/j.1755-3768.2012.02498.x.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Al Tamimi M, Hemachandran S, Al-Mezaine HS, Al-Muammar A, Kangave D. Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids. Acta Ophthalmol. 2013;91(6):e486–e493. doi:10.1111/aos.12127.
   PubMed Web of Science ®Google Scholar
• Chee SP, Jap A, Bacsal K. Prognostic factors of Vogt-Koyanagi-Harada disease in Singapore. Am J Ophthalmol. 2009;147(1):154–61 e1. doi:10.1016/j.ajo.2008.07.044.
   PubMed Web of Science ®Google Scholar
• Wu W, Wen F, Huang S, Luo G, Wu D. Choroidal folds in Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2007;143(5):900–901. doi:10.1016/j.ajo.2006.11.050.
   PubMed Web of Science ®Google Scholar
• Zhao C, Zhang M, Wen X, Dong F, Han B, Du H. Choroidal folds in acute Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm. 2009;17(4):282–288. doi:10.1080/09273940902807930.
   PubMed Web of Science ®Google Scholar
• Tsuboi K, Nakai K, Iwahashi C, Gomi F, Ikuno Y, Nishida K. Analysis of choroidal folds in acute Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2015;253(6):959–964. doi:10.1007/s00417-015-2945-y.
   PubMed Web of Science ®Google Scholar
• Hosoda Y, Uji A, Hangai M, Morooka S, Nishijima K, Yoshimura N. Relationship between retinal lesions and inward choroidal bulging in Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2014;157(5):1056–1063. doi:10.1016/j.ajo.2014.01.015.
   PubMed Web of Science ®Google Scholar
• Hashizume K, Imamura Y, Fujiwara T, Machida S, Ishida M, Kurosaka D. Retinal pigment epithelium undulations in acute stage of Vogt-Koyanagi-Harada disease: biomarker for functional outcomes after high-dose steroid therapy. Retina. 2016;36(2):415–421. doi:10.1097/IAE.0000000000000728.
   PubMed Web of Science ®Google Scholar
• Morita C, Sakata VM, Rodriguez EE, et al. Fundus autofluorescence as a marker of disease severity in Vogt-Koyanagi-Harada disease. Acta Ophthalmol. 2016;94(8):e820–e1. doi:10.1111/aos.13147.
   PubMed Web of Science ®Google Scholar
• Chee SP, Jap A, Cheung CM. The prognostic value of angiography in Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2010;150(6):888–893. doi:10.1016/j.ajo.2010.06.029.
   PubMed Web of Science ®Google Scholar
• Nakayama M, Keino H, Okada AA, et al. Enhanced depth imaging optical coherence tomography of the choroid in Vogt-Koyanagi-Harada disease. Retina. 2012;32(10):2061–2069. doi:10.1097/IAE.0b013e318256205a.
   PubMed Web of Science ®Google Scholar
• Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131(5):647–652. Doi:10.1016/s0002-9394(01)00925-4.
   PubMed Web of Science ®Google Scholar
• Chee SP, Jap A. The outcomes of indocyanine green angiography monitored immunotherapy in Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2013;97(2):130–133. doi:10.1136/bjophthalmol-2012-302538.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature Working G. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140(3):509–516. doi:10.1016/j.ajo.2005.03.057.
   PubMed Web of Science ®Google Scholar
• Okunuki Y, Tsubota K, Kezuka T, Goto H. Differences in the clinical features of two types of Vogt-Koyanagi-Harada disease: serous retinal detachment and optic disc swelling. Jpn J Ophthalmol. 2015;59(2):103–108. doi:10.1007/s10384-014-0367-8.
   PubMed Web of Science ®Google Scholar
• Ikeda N, Ikeda T, Iwami H. Detection of asymptomatic choroiditis by fundus examination in Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm. 2017;25(6):830–833. doi:10.1080/09273948.2016.1184283.
   PubMed Web of Science ®Google Scholar
• Chee SP, Chan SN, Jap A. Comparison of enhanced depth imaging and swept source optical coherence tomography in assessment of choroidal thickness in Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm. 2017;25(4):528–532. doi:10.3109/09273948.2016.1151896.
   PubMed Web of Science ®Google Scholar
• Ishihara K, Hangai M, Kita M, Yoshimura N. Acute Vogt-Koyanagi-Harada disease in enhanced spectral-domain optical coherence tomography. Ophthalmology. 2009;116(9):1799–1807. doi:10.1016/j.ophtha.2009.04.002.
   PubMed Web of Science ®Google Scholar
• Chee SP, Luu CD, Cheng CL, Lim WK, Jap A. Visual function in Vogt-Koyanagi-Harada patients. Graefes Arch Clin Exp Ophthalmol. 2005;243(8):785–790. doi:10.1007/s00417-005-1156-3.
   PubMed Web of Science ®Google Scholar